Respiration Kits

Parallel detection of SARS-CoV-2, Influenza A & B, RSV

SARS-CoV-2 Diagnostic Kits

More than 6 million tests performed

Introducing DIANA Biotechnologies

  • Founded in 2018 with a private investment of ~ 4M EUR
  • Development of DIANA technology –”the Best Czech Innovation in 2017″
  • The biggest producer of PCR diagnostics in the Czech Republic
    • 100 employees, top scientists & developers (Biology, Chemistry, IT and Automation)
  • Global ambitions with globally unique biotech products

Our 4 main business segments

  • Development and production of innovative PCR diagnostics (incl. direct PCR technology)
  • Ladership in PCR testing of COVID-19 and other respiratory viruses
  • In-house bioinformatics, enzyme development, oligo synthesis
  • Early drug discovery platform: assay development, HST screening, selectivity profiling, ADME testing
  • CRO services for pharma industry
  • In-house programs in virology and oncology
  • Unique pipeline for development of high-affinity monoclonal antibodies
  • Protein, peptide and small molecular targets, both diagnostic and therapeutic applications
  • DIANA technology-based methods for ultra-sensitive detection of biomarkers
  • Assay development for biotech industry

Integrated manufacturer of high-quality PCR diagnostics

The largest producer of COVID-19 PCR tests in Czechia

Media coverage